ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,942.47
1.26%
Dow Jones
42,732.13
0.80%
US Dollar vs MXN
20.6314
0.01%
Brent Oil
76.495
0.00%
Bitcoin
97,740.39
-0.37%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC

  6. Novartis Ag Basel Namen Akt (PK) (NVSEF) Cotización

Novartis Ag Basel Namen Akt (PK)

Novartis Ag Basel Namen Akt (PK) (NVSEF)

USOTC
96.322
-0.604
(-0.62%)
Cerrado 04 Enero 3:00PM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
96.322
Postura de Compra
93.47
Postura de Venta
101.50
Volume Operado de la Acción
24,130
96.322 Rango del Día 96.322
90.24 Rango de 52 semanas 123.55
Capitalización de Mercado [m]
204.014B
Precio Anterior
96.926
Precio de Apertura
96.322
Hora
6
@
100.1
Última hora de negociación
Volumen financiero
US$ 2,324,250
Precio Promedio Ponderado
96.322
Volumen promedio (3 m)
48,203
Acciones en circulación
2,118,043,712
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
13.73
Beneficio por acción (BPA)
7.01
turnover
54.11B
Beneficio neto
14.85B

Acerca de Novartis Ag Basel Namen Akt (PK)

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.novartis.com
Sede
Basel, Che
Fundado
-
Novartis Ag Basel Namen Akt (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker NVSEF. The last closing price for Novartis Ag Basel Namen ... (PK) was US$96.93. Over the last year, Novartis Ag Basel Namen ... (PK) shares have traded in a share price range of US$ 90.24 to US$ 123.55.

Novartis Ag Basel Namen ... (PK) currently has 2,118,043,712 shares in issue. The market capitalisation of Novartis Ag Basel Namen ... (PK) is US$205.29 billion. Novartis Ag Basel Namen ... (PK) has a price to earnings ratio (PE ratio) of 13.73.

NVSEF Últimas noticias

Más noticias

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

29 Octubre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

18 Septiembre 2024
Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]

17 Septiembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

17 Septiembre 2024
Edgar (US Regulatory)

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

16 Septiembre 2024
Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

10 Junio 2024
Edgar (US Regulatory)

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

04 Junio 2024
Edgar (US Regulatory)

Form SD - Specialized disclosure report

31 Mayo 2024
Edgar (US Regulatory)

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

16 Mayo 2024
Edgar (US Regulatory)

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

13 Mayo 2024
Edgar (US Regulatory)
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-2.183-2.2161311608598.50598.50596.156596.57909681CS
4-2.428-2.4587341772298.7598.771194.696104596.62391271CS
12-19.378-16.7484874676115.7117.973394.69648203104.3857137CS
26-8.358-7.98433320596104.68123.5594.69629268105.47148323CS
52-6.908-6.69185314347103.23123.5590.2431292104.02260249CS
1567.7528.7523992322588.57123.5572.984752990.45401574CS
2602.2822.4266269672594.04123.5568.654406888.79875293CS

NVSEF - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Novartis Ag Basel Namen ... (PK)?
El precio actual de las acciones de Novartis Ag Basel Namen ... (PK) es US$ 96.322
¿Cuántas acciones de Novartis Ag Basel Namen ... (PK) están en circulación?
Novartis Ag Basel Namen ... (PK) tiene 2,118,043,712 acciones en circulación
¿Cuál es la capitalización de mercado de Novartis Ag Basel Namen ... (PK)?
La capitalización de mercado de Novartis Ag Basel Namen ... (PK) es USD 205.29B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Novartis Ag Basel Namen ... (PK)?
Novartis Ag Basel Namen ... (PK) ha negociado en un rango de US$ 90.24 a US$ 123.55 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Novartis Ag Basel Namen ... (PK)?
El ratio precio/beneficio de Novartis Ag Basel Namen ... (PK) es 13.73
¿Cuál es el ratio de efectivo a ventas de Novartis Ag Basel Namen ... (PK)?
El ratio de efectivo a ventas de Novartis Ag Basel Namen ... (PK) es 3.77
¿Cuál es la moneda de reporte de Novartis Ag Basel Namen ... (PK)?
Novartis Ag Basel Namen ... (PK) presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Novartis Ag Basel Namen ... (PK)?
El último ingresos anual de Novartis Ag Basel Namen ... (PK) es USD 54.11B
¿Cuál es el último beneficio anual de Novartis Ag Basel Namen ... (PK)?
El último beneficio anual de Novartis Ag Basel Namen ... (PK) es USD 14.85B
¿Cuál es la dirección registrada de Novartis Ag Basel Namen ... (PK)?
La dirección registrada de Novartis Ag Basel Namen ... (PK) es PO BOX, BASEL, 4002
¿Cuál es la dirección del sitio web de Novartis Ag Basel Namen ... (PK)?
La dirección del sitio web de Novartis Ag Basel Namen ... (PK) es www.novartis.com
¿En qué sector industrial opera Novartis Ag Basel Namen ... (PK)?
Novartis Ag Basel Namen ... (PK) opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
EGIOQEdgio Inc (CE)
US$ 0.01
(999,900.00%)
584
AAGRAfrican Agriculture Holdings Inc (CE)
US$ 0.008
(799,900.00%)
477
THCBFTHC Biomed International Limited (CE)
US$ 0.001
(99,900.00%)
100
AEORFAEON REIT Investment Corporation (PK)
US$ 796.08
(26,436.00%)
1
EFTReFFECTOR Therapeutics Inc (CE)
US$ 0.0002
(19,900.00%)
225
UFABQUnique Fabricating Inc (CE)
US$ 0.000001
(-99.98%)
102.53k
VICFFVice Health and Wellness Inc (CE)
US$ 0.000001
(-99.97%)
996
SAFSSafer Shot Inc (CE)
US$ 0.000001
(-99.93%)
2.54M
ERFBERF Wireless Inc (CE)
US$ 0.0001
(-99.89%)
99.77k
ARVLFArrival (CE)
US$ 0.0002
(-99.60%)
42.86k
AITXArtificial Intelligence Technology Solutions Inc (PK)
US$ 0.0038
(52.00%)
608.97M
HMBLHUMBL Inc (PK)
US$ 0.0009
(0.00%)
546.25M
PHILPHI Group Inc (PK)
US$ 0.0003
(0.00%)
501.07M
CBIACanopus Biopharma Inc (PK)
US$ 0.0002
(100.00%)
281.95M
RDARRaadr Inc (PK)
US$ 0.00125
(-10.71%)
169.44M

Discusión

Ver feed completo
Bull_Dolphin Bull_Dolphin 4 minutos hace
When a B-17 tail fell with a gunner inside. Video reenactment:

https://www.youtube.com/watch?v=ftC82XScxV4
ksquared ksquared 6 minutos hace
P.S. Looks really awful for Louisville, Larry.
Ending with copious amounts of ice is deadly.
Scary stuff.
Hope the power stays on for you. Stay safe.
InfiniteForest34 InfiniteForest34 8 minutos hace
Is this really going to $10,000.00? When will it get there?
XRPUSD
ubueltp ubueltp 11 minutos hace
I will look for quotes next week. I’m working long hours this weeekend.
ELTP
ksquared ksquared 11 minutos hace
Morning, Larry. I'm listening to The Weather Channel's storm hype for "Blair" as I type.
You have my condolences.
As I just posted to cap... it is supposed to travel south of us. Thank God.
I can tell I'm getting old. Anything more than 3" is too much for me.
BigCat BigCat 11 minutos hace
Another well above average volume day yesterday... interesting. This ticker usually sees about 10,000 a day, yesterday we were over 70,000.
BXSY
Investor2014 Investor2014 15 minutos hace
ChatGPT review - don't shoot the messenger. Well you can if you want and no doubt will get the usual emojis be it as it may.
------

After reviewing the paper “Blarcamesine for the treatment of Early Alzheimer’s Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial,” h
AVXL
powerwalker powerwalker 16 minutos hace
ignatiusrielly35, did not he also recommend SAVA as the alternative to Anavex if one was investing in the Alzheimer's race.
AVXL
SkeBallLarry SkeBallLarry 16 minutos hace
" I got Winter-Storm *Warning* for 2Moro, K2 " .. !!
weedtrader420 weedtrader420 17 minutos hace
XRP ☝️😎☝️
XRPUSD
Horseb4CarT Horseb4CarT 18 minutos hace
Oh come on now!

It's public knowledge that the MAA is in the MHRA's hands and there will be a decision by the MHRA, and they are caught up. 

It's coming, and it's not going to take another year imo, and consensus is any day now. 
NWBO
ksquared ksquared 19 minutos hace
Good Morning, cap. Merchan can rot in hell.
Per legal commentator Jonathan Turley on FOX last night, this gives demorrhoids their "convicted felon" talking point once Trump is officially sentenced.
I admire Trump's strength.
Will this harassment ever end?
powerwalker powerwalker 22 minutos hace
I might add that "Alzheimer's and Dementia" is published by the Alzheimer's Association, which receives much, much and much of its funding from BP.

Not likely that it would publish Anavex's results.
AVXL
Viking61 Viking61 24 minutos hace
Amen brother Wings! Hey are you still flying or did you retire?
FNMA
Here Today Here Today 27 minutos hace
What's strange is that volume I see on the ticker is 2,980,268 share volume but IHub shows a volume of over 5 million. I guess IHub's is incorrect?
VDRM
ksquared ksquared 33 minutos hace
Biden to present Hillary Clinton, George Soros and 17 others the Presidential Medal of Freedom
By Victor Nava Published Jan. 4, 2025, 5:00 a.m. ET
(Most of the choices sicken and infuriate me... especially Soros and Clinton.)

President Biden will award the President
Wingsjr Wingsjr 35 minutos hace
I find myself this morning hating that it’s the Weekend. Damn we were printing money going into the close. 🤑🤑🤑
FNMA
Jagman5 Jagman5 35 minutos hace
I guarantee there is a plan in place as to how to spend that $2 mil, we just don't know what it is (as usual).

$NXPL
NXPL
Golden Cross Golden Cross 36 minutos hace
The PSAR flipped bullish on the chart yesterday. This is a strong bullish signal and ILLR has had nice moves when this happens. I time my buys by this. I will be adding here. The last time it flipped bullish it went to the ~$4.75 area.
$ILLR
https://investorshub.advfn.com/uimage/upload
ILLR
PEACHMAN PEACHMAN 38 minutos hace
Actually,I know Mike and he is telling the truth.Buying shares at .02 was smart.My dad and I bought shares at .004 that also was smart. It just proves that paid bashers on Ihub continue to lie about IFUS and it's shareholders holding for the. long term.

Flacrusher33 does not care what
IFUS
Golden Cross Golden Cross 38 minutos hace
$ILLR The PSAR flipped bullish on the chart yesterday. This is a strong bullish signal and ILLR has had nice moves when this happens. I time my buys by this. I will be adding here. The last time it flipped bullish it went to the ~$4.75 area.

https://investorshub.advfn.com/uimage/uploa
ILLR
thistraderknowsall thistraderknowsall 39 minutos hace
ASM crypto HUGE $1 RUN UP UNDERWAY!
Breakout!!!!!

Great news!!!!
ASM
TrendTrade2016 TrendTrade2016 40 minutos hace
XBOTF/XBOT...READY FOR BREAK OUT...NOT JUST A ROBOT COMPANY...THEY HOLD ETH AND SOL...COMPANY DOES NOT NEED TO RAISE CAPITAL...THEY USE THEIR CRYPTO HOLDING TO FINANCE OPERATIONS
XBOTF

Su Consulta Reciente

USOTC
NVSEF
Novartis Ag Basel Namen ... (PK)
BIT
S27192
Societe Generale Effekten
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados